Download PDF
Thromb Haemost 2001; 86(02): 712-713
DOI: 10.1055/s-0037-1616121
Letters to the Editor
Schattauer GmbH

The Effects of Transdermal and Oral Estrogen/Progesterone Regimens on Free and Total Protein S in Postmenopausal Women

V. Marque
1   The National Institute of Health and Medical Research (INSERM) Unit 258, Paris, France
,
M. Alhenc-Gelas
2   Hôpital Européen Georges Pompidou, Service d’Hématologie Biologique A, and INSERM Unit 428, Paris, France
,
G. Plu-Bureau
1   The National Institute of Health and Medical Research (INSERM) Unit 258, Paris, France
,
E. Oger
1   The National Institute of Health and Medical Research (INSERM) Unit 258, Paris, France
,
P. Y. Scarabin
1   The National Institute of Health and Medical Research (INSERM) Unit 258, Paris, France
› Author Affiliations
Further Information

Publication History

Received 22 January 2001

Accepted after resubmission 21 March 2001

Publication Date:
12 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Esmon CT. Regulation of blood coagulation. Bio Biophys Acta 2000; 1477: 349-60.
    PubMedGoogle Scholar
  • 2 Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and protein S deficiencies. Semin Hematol 1997; 34: 205-16.
    PubMedGoogle Scholar
  • 3 Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Reitsma PH, Formstone C, Cooper DN, Saito H, Suzuki K, Bernardi F, Aiach M. A database of mutations – summary of the first update. Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2000; 84: 918.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Oger E, Scarabin PY. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy. Drugs Aging 1999; 14: 55-61.
    CrossrefPubMedGoogle Scholar
  • 5 Hulley S, Crady C, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. for the heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-13.
    CrossrefPubMedGoogle Scholar
  • 6 Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal Estrogen/Progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997; 17: 3071-8.
    CrossrefPubMedGoogle Scholar
  • 7 Van Baal MW, Emeis JJ, van der Mooren MJ, Kessel H, Kenemans P, Stehouwer CDA. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomized, placebo-controlled 12-week study. Thromb Haemost 2000; 83: 29-34.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Caine YG, Bauer KA, Barzegar S, ten Cate H, Sacks FM, Walsh BW, Schiff I, Rosenberg RD. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost 1992; 68: 392-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 The Writing group for the clotting factors study.. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. Thromb Haemost 1996; 75: 476-80.
    Article in Thieme ConnectPubMedGoogle Scholar